Clinical Practice Session
A Look in the Crystal Ball: COVID-19 and the Future of Outpatient Dialysis
November 03, 2022 | 02:00 PM - 04:00 PM
Location: WF2 Tangerine, Orange County Convention Center, West Building
Session Description
This session reviews the impact of COVID-19 on outpatient dialysis. Discussions include the effect of COVID-19 on dialysis staffing and ability to provide safe treatments to everyone in need, the efficacy of vaccines against COVID-19, including new agents in development focused on T cells, and the utility of antibody testing to determine kidney patient immune status. Also considered are the delays in access to new therapies against COVID-19 due to their lack of inclusion in clinical trials, and the ethics of vaccine and booster mandates against COVID-19 and other infectious diseases.
ASN thanks the ASN COVID-19 Response Team for assistance with this session.
Learning Objective(s)
- Evaluate the impact of COVID-19 on staffing in dialysis facilities
- List tools to evaluate the immune status of patients with kidney diseases
- Assess the efficacy of current and future vaccines against COVID-19 for patients with kidney diseases
- Discuss the reasons for delays in access to new therapies for patients with kidney diseases and what can be done about them
- Examine the ethics of mandatory vaccination against COVID-19 and other infectious diseases
Learning Pathway(s)
- Dialysis
- Pharmacology
Moderators
- Brigitte Schiller, MD, FASN
- Jeffrey I. Silberzweig, MD, FASN
Presentations
- Dialysis Facility Staffing in the Wake of COVID-19
02:00 PM - 02:30 PM
Jeffrey L. Hymes, MD
- Vaccine Requirements: Are Mandates Ethical?
02:30 PM - 03:00 PM
Olivia S. Kates, MA, MD
- ESRD Network Roles: Patient Resources and Regulatory
03:00 PM - 03:30 PM
Kamyar Kalantar-Zadeh, DrMed, MD, PhD, MPH, FASN
- Most Important Good and Bad Impacts of COVID in Dialysis
03:30 PM - 04:00 PM
Dawn Edwards
